Archiv der Pharmazie p. 233 - 234 (1997)
Update date:2022-08-05
Topics: Synthesis NMR spectroscopy Mass spectrometry Reaction Conditions In vitro assay Bone resorption
Pifferi, Giorgio
Da Re, Paolo
Valenti, Piero
Bisi, Alessandra
Malandrino, Salvatore
A topological modification of ipriflavone 1, a recent antiosteoporotic drug, is described, The flavone moiety of 1 has been replaced by a xanthone one, Among the new derivatives, the 3,6-diisopropoxyxanthone (2a) has shown significant bone resorption inhibition in in vitro and in vivo tests.
View MoreShanghai doly chemical Co.,Ltd
Contact:+86-21-34716221
Address:No.328,WuHe Roard,MinHang,ShangHai China
suzhou chukai pharmateach co,.ltd
Contact:86-512-88812511
Address:Building 3, Wujiang Scientific Innovation Park, 2358 Changan Rd, Wujiang 215200, Jiangsu Province, P. R. China
Guangzhou Congen Pharmatec Co.,Ltd.
website:https://www.congenpharma.com
Contact:86-020-82350801
Address:Room 501, Building G11, South China Advanced Materials Innovation Park, 31 Kefeng Road, Science City, Guangzhou, China 510663
Heliosense Biotechnologies, Inc.
website:https://www.heliosense.com/
Contact:+86-592-5667290
Address:Xiamen Torch Hi-tech Zone Venture Weiye Building S506
Geen Chemical Technology Co., Ltd
Contact:86-769-21660847
Address:1408, Yingfeng Commercial Center, Nancheng District
Doi:10.1002/jps.2600650319
(1976)Doi:10.1021/ja00422a036
(1976)Doi:10.1021/ja01566a077
(1957)Doi:10.1139/v00-113
(2000)Doi:10.1021/jo034447c
(2003)Doi:10.1021/jacs.1c05852
(2021)
